search
Back to results

Lifestyle Program for Obstructive Sleep Apnea With Severe Obesity

Primary Purpose

Obstructive Sleep Apnea, Obesity

Status
Not yet recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Home-based pulmonary rehabilitation (PR) system
Sponsored by
Mayo Clinic
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Obstructive Sleep Apnea

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult patients, 18 years of age or older.
  • Newly diagnosed with severe Obstructive Sleep Apnea (OSA) and severe obesity (BMI > 35).

Exclusion Criteria:

  • Individuals < 18 years of age.
  • Patients with an inability to provide good data or follow commands (patients who are disoriented, have a severe neurologic or psychiatric condition).

Sites / Locations

  • Mayo Clinic in Rochester

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Severe Comorbid OSA

Arm Description

Newly-diagnosed severe comorbid obstructive sleep apnea subjects will use technology to facilitate remote health coaching through a home-based pulmonary rehabilitation (PR) system

Outcomes

Primary Outcome Measures

Feasibility of proposed system in patients with OSA and Obesity
Qualitative Interview

Secondary Outcome Measures

Full Information

First Posted
April 18, 2022
Last Updated
October 13, 2023
Sponsor
Mayo Clinic
search

1. Study Identification

Unique Protocol Identification Number
NCT05343000
Brief Title
Lifestyle Program for Obstructive Sleep Apnea With Severe Obesity
Official Title
A Lifestyle Program for Severe Comorbid Obstructive Sleep Apnea With Severe Obesity
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
November 1, 2023 (Anticipated)
Primary Completion Date
June 2024 (Anticipated)
Study Completion Date
June 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Mayo Clinic

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to develop a data driven system for persons with severe obesity sleep apnea that utilizes remote monitoring with health coaching to create behavior changes aimed at improving health and quality of life.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obstructive Sleep Apnea, Obesity

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Pilot study
Masking
None (Open Label)
Allocation
N/A
Enrollment
15 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Severe Comorbid OSA
Arm Type
Experimental
Arm Description
Newly-diagnosed severe comorbid obstructive sleep apnea subjects will use technology to facilitate remote health coaching through a home-based pulmonary rehabilitation (PR) system
Intervention Type
Behavioral
Intervention Name(s)
Home-based pulmonary rehabilitation (PR) system
Intervention Description
Technology to facilitate remote health coaching through PAP management, sleep scheduling, sleep duration, diet, exercise, medication and more. The tablet and sensors upload the patient's activities, physiological data, and answers to the daily self-report questions to a secure website. This website also allows health coaches to view patient data via overview, weekly, daily, and trend reports. Health coaches call patients regularly to celebrate progress, assist with any issues, and set new goals.
Primary Outcome Measure Information:
Title
Feasibility of proposed system in patients with OSA and Obesity
Description
Qualitative Interview
Time Frame
Qualitative Interviews will be completed at the end of the two week trial

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult patients, 18 years of age or older. Newly diagnosed with severe Obstructive Sleep Apnea (OSA) and severe obesity (BMI > 35). Exclusion Criteria: Individuals < 18 years of age. Patients with an inability to provide good data or follow commands (patients who are disoriented, have a severe neurologic or psychiatric condition).
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Johanna Hoult, MA
Phone
507-293-1989
Email
hoult.johanna@mayo.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Joshua Taylor
Phone
507-293-1989
Email
taylor.joshua@mayo.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Roberto Benzo, MD
Organizational Affiliation
Mayo Clinic
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mayo Clinic in Rochester
City
Rochester
State/Province
Minnesota
ZIP/Postal Code
55905
Country
United States

12. IPD Sharing Statement

Links:
URL
https://www.mayo.edu/research/clinical-trials
Description
Mayo Clinic Clinical Trials

Learn more about this trial

Lifestyle Program for Obstructive Sleep Apnea With Severe Obesity

We'll reach out to this number within 24 hrs